Preferred Label : sofosbuvir-velpatasvir drug combination;
MeSH synonym : sofosbuvir velpatasvir drug combination; sofosbuvir, velpatasvir drug combination;
Origin ID : C000611331;
UMLS CUI : C4271578;
ATC code(s)
- Automatic exact mappings (from CISMeF team)
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
https://www.has-sante.fr/jcms/p_3152667/fr/epclusa
2020
false
false
false
France
Sofosbuvir
velpatasvir
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
hepatitis C, chronic
evaluation of the transparency committee
Epclusa
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
---
https://www.has-sante.fr/jcms/p_3224423/fr/epclusa
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
sofosbuvir-velpatasvir drug combination
antiviral agents
Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product
form)
sofosbuvir and velpatasvir
hepatitis C, chronic
adult
adolescent
child
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings
---
https://www.has-sante.fr/jcms/p_3115175/fr/epclusa
2019
false
false
false
France
sofosbuvir and velpatasvir
hepatitis C, chronic
evaluation of the transparency committee
sofosbuvir-velpatasvir drug combination
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings
---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal
product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00329
2016
false
false
false
Canada
French
drug information
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings
---
https://www.ema.europa.eu/medicines/human/EPAR/Epclusa
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
velpatasvir
velpatasvir
drug combinations
Sofosbuvir
Sofosbuvir
antiviral agents
antiviral agents
pregnancy
breast feeding
drug interactions
hepatitis C, chronic
adult
administration, oral
drug therapy, combination
NS-5a protein, hepatitis C virus
enzyme inhibitors
enzyme inhibitors
RNA-Dependent RNA Polymerase
product surveillance, postmarketing
aged
drug evaluation, preclinical
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
NS-5 protein, hepatitis C virus
viral nonstructural proteins
carbamates
Heterocyclic Compounds, 4 or More Rings
carbamates
Heterocyclic Compounds, 4 or More Rings
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
---
http://www.has-sante.fr/portail/jcms/c_2724396/fr/epclusa
http://www.has-sante.fr/portail/jcms/c_2724396/fr/epclusa-sofosbuvir/velpatasvir-association-fixe-d-antiviraux-a-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
drug combinations
Sofosbuvir
Sofosbuvir
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
velpatasvir
velpatasvir
hepatitis C, chronic
adult
guidelines for drug use
sofosbuvir-velpatasvir drug combination
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
drug combinations
---
